Sang Seong Kim

Prof. Sang Seong Kim

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GCGa-Young Choi
Ga-Young Choi
HKHyun-Bum Kim
Hyun-Bum Kim
EHEun-Sang Hwang
Eun-Sang Hwang
SLSeok Lee
Seok Lee
MKMin-Ji Kim
Min-Ji Kim
JPJi-Ho Park
Ji-Ho Park
Curcumin is a major diarylheptanoid component ofCurcuma longawith traditional usage for anxiety and depression. It has been known for the anti-inflammatory, antistress, and neurotropic effects. Here we examined curcumin effect in neural plasticity and cell viability. 60-channel multielectrode array was applied on organotypic hippocampal slice cultures (OHSCs) to monitor the effect of 10 μM curcumin in long-term depression (LTD) through low-frequency stimulation (LFS) to the Schaffer collaterals and commissural pathways. Cell viability was assayed by propidium iodide uptake test in OHSCs. In addition, the influence of oral curcumin administration on rat behavior was assessed with the forced swim test (FST). Finally, protein expression levels of brain-derived neurotrophic factor (BDNF) and cyclooxygenase-2 (COX-2) were measured by Western blot in chronically stressed rats. Our results demonstrated that 10 μM curcumin attenuated LTD and reduced cell death. It also recovered the behavior immobility of FST, rescued the attenuated BDNF expression, and inhibited the enhancement of COX-2 expression in stressed animals. These findings indicate that curcumin can enhance postsynaptic electrical reactivity and cell viability in intact neural circuits with antidepressant-like effects, possibly through the upregulation of BDNF and reduction of inflammatory factors in the brain.

Verified
Journal Article
Open access
PDF file
EKEunyoung Kim
Eunyoung Kim
UOUndarmaa Otgontenger
Undarmaa Otgontenger
Ariunzaya JamsranjavAriunzaya Jamsranjav
Ariunzaya Jamsranjav
SKSang Seong Kim
Sang Seong Kim
The deterioration of neurons in Alzheimer’s disease (AD) arises from genetic, immunologic, and cellular factors inside the cortex. The traditional consensus of the amyloid-beta (Aβ) paradigm as a singular cause of AD has been under revision, with the accumulation of exploding neurobiological evidence. Among the multifaceted casualties of AD, the involvement of glia gains significance for its dynamic contribution to neurons, either in a neuroprotective or neurotoxic fashion. Basically, microglia and astrocytes contribute to neuronal sustainability by releasing neuroprotective cytokines, maintaining an adequate amount of glutamate in the synapse, and pruning excessive synaptic terminals. Such beneficial effects divert to the other detrimental cascade in chronic neuroinflammatory conditions. In this change, there are new discoveries of specific cytokines, microRNAs, and complementary factors. Previously unknown mechanisms of ion channels such as Kv1.3, Kir2.1, and HCN are also elucidated in the activation of microglia. The activation of glia is responsible for the excitotoxicity through the overflow of glutamate transmitter via mGluRs expressed on the membrane, which can lead to synaptic malfunction and engulfment. The communication between microglia and astrocytes is mediated through exosomes as well as cytokines, where numerous pieces of genetic information are transferred in the form of microRNAs. The new findings tell us that the neuronal environment in the AD condition is a far more complicated and dynamically interacting space. The identification of each molecule in the milieu and cellular communication would contribute to a better understanding of AD in the neurobiological perspective, consequently suggesting a possible therapeutic clue.

15 December 2015 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
SKSang Seong Kim
Sang Seong Kim
LMLimei Ma
Limei Ma
JUJay Unruh
Jay Unruh
SMSean McKinney
Sean McKinney
CYC. Ron Yu
C. Ron Yu
The vomeronasal organ (VNO) is specialized in detecting pheromone and heterospecific cues in the environment. Recent studies demonstrate the involvement of multiple ion channels in VNO signal transduction, including the calcium-activated chloride channels (CACCs). Opening of CACCs appears to result in activation of VNO neuron through outflow of Cl− ions. However, the intracellular Cl− concentration remains undetermined. We used the chloride ion quenching dye, MQAE, to measure the intracellular Cl− concentration of VNO neuron in live VNO slices. The resting Cl− concentration in the VNO neurons is measured at 84.73 mM. Urine activation of the VNO neurons causes a drop in Cl− concentration, consistent with the notion of an efflux of Cl− to depolarize the cells. Similar observation is made for VNO neurons from mice with deletion of the transient receptor potential canonical channel 2 (TRPC2), which have a resting Cl− concentrations at 81 mM. The VNO neurons rest at high intracellular Cl− concentration, which can lead to depolarization of the cell when chloride channels open. These results also provide additional support of TRPC2-independent pathway of VNO activation.

1 June 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
EHEun-Sang Hwang
Eun-Sang Hwang
HKHyun-Bum Kim
Hyun-Bum Kim
GCGa-Young Choi
Ga-Young Choi
SLSeok Lee
Seok Lee
SLSung-Ok Lee
Sung-Ok Lee
JPJi-Ho Park
Ji-Ho Park

5 April 2013 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
SKSang Seong Kim
Sang Seong Kim
SHSun Wook Hwang
Sun Wook Hwang

1 January 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GLGum Hwa Lee
Gum Hwa Lee
SKSang Seong Kim
Sang Seong Kim
Chronic pain originating from neuronal damage remains an incurable symptom debilitating patients. Proposed molecular modalities in neuropathic pain include ion channel expressions, immune reactions, and inflammatory substrate diffusions. Recent advances in RNA sequence analysis have discovered specific ion channel expressions in nociceptors such as transient receptor potential (TRP) channels, voltage-gated potassium, and sodium channels. G protein-coupled receptors (GPCRs) also play an important role in triggering surrounding immune cells. The multiple protein expressions complicate therapeutic development for neuropathic pain. Recent progress in optogenetics and pharmacogenetics may herald the development of novel therapeutics for the incurable pain. Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) facilitate the artificial manipulation of intracellular signaling through excitatory or inhibitory G protein subunits activated by biologically inert synthetic ligands. Expression of excitatory channelrhodopsins and inhibitory halorhodopsins on injured neurons or surrounding cells can attenuate neuropathic pain precisely controlled by light stimulation. To achieve the discrete treatment of injured neurons, we can exploit the transcriptome database obtained by RNA sequence analysis in specific neuropathies. This can recommend the suitable promoter information to target the injury sites circumventing intact neurons. Therefore, novel strategies benefiting from pharmacogenetics, optogenetics, and RNA sequencing might be promising for neuropathic pain treatment in future.